19-21/11/2020 Despite CoViD19 pandemic predicaments, IASIS PHARMA successfully participated in the 20th Panhellenic Hypertension Conference Webinar, organized by the Hellenic Hypertension Society (HHS), which took place on November 19-21, 2020. IASIS PHARMA supported the HHS effort, as there is an increasing number of adults in Greece having high blood pressure. At the same time, there [...]
Hellenic Gastroenterological Society Amphitheater, Athens, 6 - 7/11/2020 Despite Coronavirus pandemic predicament, IASIS PHARMA, with high sense of responsibility, successfully participated as a Gold Sponsor in the “25th Hellenic Conference of the Helicobacter Pylori & other Digestive Infections”. The conference was organized by the “Hellenic Society of Gastroenterology and the “Hellenic Society for Infectious Diseases” [...]
IASIS PHARMA, consistently aware of its responsibility to serve at the highest possible level both health care professionals and patients, introduces to the pharmaceutical market Sensibio® in 30 g. new package. Sensibio® 30 g. new package was launched to the market in order to complete Sensibio® 15 g., the well-established fixed combination of Fusidic acid (antibiotic) and [...]
IASIS PHARMA, consistently aware of its responsibility to serve at the highest possible level both health care professionals and patients, introduces to the pharmaceutical market Flusterix® in 30 g. new package. Flusterix® 30 g. was launched in order to complete the, well-established to the pharmaceutical market, Flusterix® 15 g. package. Flusterix® has Fusidic acid as its active ingredient, [...]
COVID-19 pandemic has caused an unprecedented, global health crisis. Moreover, one of the other numerous problems that COVID-19 has caused, is the lack of scientific events with physical appearance. Despite that, many scientific events are carried out online. One of these events was the Online Educational Workshop of the Professional Association of Greek Gastroenterologists (EP.E.G.E), [...]
IASIS PHARMA, compliant to its social corporate responsibility, after the free-of-charge production of 28.700lt of antiseptic solution for the Greek public health system, this time and in order all IASIS PHARMA employees to return to their jobs as safely as possible, carried out several pre-planned actions: - All IASIS PHARMA employees passed from covid-19 tests. [...]
For the extremely demanding pharmaceutical form of effervescent tablets, IASIS PHARMA chooses IMA technology, to combine top of the line quality with very high production capacity. IASIS PHARMA brand new pharma grade effervescent manufacturing facility is part of its second, 45.000m2 manufacturing site that became operational in 2019, in Koropi, Athens. The effervescent manufacturing facility is a [...]
Putting the emphasis on Authenticity. European Medicines Agency (EMA) recognized Chios Mastic as a medicine of herbal origin at the meeting that took place in London, on August 7 2015. The decision was unanimous and Chios Mastic was accepted to be included in the category of traditional herbal medicines. IASIS PHARMA played a pivotal role in the recognition of Chios Mastic both at European [...]
The pandemic that was spread by COVID-19, apart from the irreplaceable loss of human life, also caused several shocks to the global economy and entrepreneurship. Nevertheless, under the auspices of the Panhellenic Association of Pharmaceutical Industry (PEF), Greek pharmaceutical companies stepped in to support both the Greek State and the patients. IASIS PHARMA played a [...]
During the past months, Greece, just like the rest of the world, faced an unprecedented health crisis· COVID-19 corona virus pandemic, in addition to the irreplaceable loss of human life, has caused extremely adverse conditions in all areas of the economy and entrepreneurship. Nevertheless, the Greek pharmaceutical industry not only endured that situation, but took [...]
